Skip to content

Public FDA record

Z-0665-2022: BD Vacutainer Luer Lok Access Device - intended as a sterile, single use device designed to provide a con

Recall record Z-0665-2022 for Becton Dickinson & Company. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0665-2022
Company in FDA record
Becton Dickinson & Company
FDA record creation date
Feb 23, 2022
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class III

Reason stated in the source

May shed contaminant particles into the urine specimen that may be misidentified as Red Blood Cells when used in conjunction with the Sysmex UF-1000i or UX-2000 Analyzers and lead to false elevations in RBC counts

Source facts

Action
BD issued Urgent Medical Device Correction letter via email to Sysmex on January 06, 2022, requesting they inform/distribute to their customers still using a Sysmex UF-1000i or UX-2000 analyzer the notification provided by BD .The scope would include any customers who were shipped Vacutainer LLAD products still using a Sysmex UF-1000i or UX-2000 analyzer. Sysmex issued letter to their customers addressed to the Urinalysis Manager instructs the customer to respond to Sysmex. 1. Sysmex customers should retain a copy of this notification and post near your analyzer as a visual reminder of this potential issue. 2. Complete the Notification Response Form to confirm receipt of this medical device correction. 3. Report any adverse health consequences experienced with the use of this product to BD. Events may also be reported to the FDA's MedWatch Adverse Event Reporting program. 1. BD is updating the IFU for the LLAD products to include a precaution to confirm any abnormal urinalysis results per facility policy/procedure and best practices and that BD Vacutainer LLAD devices are not recommended for use with Sysmex UF-1000i and UX- 2000 analyzers as it may falsely identify contaminant particles as Red Blood Cells. BD will notify Sysmex via follow-up communication when these revisions are completed (anticipated by June 2022). 2. BD continues to investigate the root cause of this issue and will apply corrective actions as appropriate. Sysmex will be notified if any additional actions are required upon completion of the root cause analysis. Product will continue to ship so as not to impact critical patient care.
Initiated
2022-01-06
Root cause
Under Investigation by firm
Distribution
US Nationwide distribution in the state of IL.
Recall number
Z-0665-2022
Recall status
Open, Classified
CDRH record ID
191724
FDA record created
2022-02-23
Recall event number
89486

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗